HORIZON-HLTH-TOOL-2022-11-01: Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers
Keywords: Biomarkers | Cardiovascular diseases | Clinical validation | Drugs | Healthcare providers | Nursing | Pharmacology
Year: 2022
Type of action: RIA
Expected EU contribution per project: 10M€
Deadline: 21/4/2022
Link
